CClinicalTrials.gg
CompletedNCT07094152Updated Jul 30, 2025

Blood Pressure Monitor (BPM1) Clinical Test (Cuff Range: 15cm-24cm, 22cm-42cm, 40-48cm)

An observational study in Blood Pressure, sponsored by Andon Health Co., Ltd. Completed at 1 site in China. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-30.

Sponsored by Andon Health Co., Ltd · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
31
Ages
12 Years and older
Sex
All
01

Study summary

The purpose of this study is to verify the accuracy of the blood pressure cuffs with blood pressure monitor device. Cuff circumference is: 15-24cm, 22-42cm, 40-48cm

02

Conditions studied

  • Blood Pressure
03

In context

Lead sponsor

Andon Health Co., Ltd is the lead sponsor of 19 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Normal blood pressure and hypertensive patients over 12 years old

Inclusion criteria

  • Normal blood pressure and hypertensive patients over 12 years old

Exclusion criteria

Exclusion Criteria:

  • Patients with serious arrhythmias or a high frequency of arrhythmias
  • Pregnant woman
  • Other investigators believe that it is not suitable to participate in this clinical trial
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
31 participants (actual)
Patient registry
No

Groups and cohorts

  • Subject use both BPM1 Blood Pressure Monitor and mercury sphygmomanometers
06

What researchers measure

Primary outcomes

  1. Blood Pressure Monitor Accuracy

    All the test results of the electronic blood pressure monitor with three (3) kinds of cuffs is within the accuracy creteria, with the merury sphygmomanometer as control

    Time frame: 30 minutes

07

Study locations

1 site
  • The First Affiliated Hospital, the Air Force Medical University
    Xi’an, Shanxi 710032, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07094152
Lead sponsor
Andon Health Co., Ltd
Responsible party
Sponsor
First posted
Jul 30, 2025
Start date
Oct 8, 2023
Primary completion
Dec 29, 2023
Completion
Dec 29, 2023
Last update
Jul 30, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion